New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Summit Therapeutics Inc.
SMMT
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

15B

Biotechnology

Next Earning date - 18 Feb 2025

15B

Biotechnology

Next Earning date - 18 Feb 2025

20.09USD

Shape-0.58 ( -2.81%)
Market Closed (as of Feb 08, 00:59 EDT)
favorite-chart

Relative Strenght

97
favorite-chart

Volume Buzz

-37%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

41%

Quote Panel

Shape
Updated February 10, 2025
1W -2.47 % 1M 10.62 % 3M -7.63 % 1Y 330.62 %

Key Metrics

Shape
  • Market Cap

    14.81B


  • Shares Outstanding

    737.10M


  • Share in Float

    114.59M


  • Dividende

    0


  • Earning Date

    18 Feb 2025


  • Price Target

    20.09


  • Average Volume

    2.15M


  • Beta

    -0.923


  • Range

    2.1-33.89


  • Industry

    Biotechnology


  • Website

    https://www.summittxinc.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

SMMT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$34M

ShapeNaN%

2025-Revenue

$0.33

Shape-328%

2025-EPS

$21M

Shape61%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Wells Fargo

initialise

Previous: Not converted

2024-12-11

Now: Overweight

JMP Securities

initialise

Previous: Not converted

2024-11-04

Now: Market Outperform

Citigroup

downgrade

Previous: Buy

2024-09-27

Now: Neutral

H.C. Wainwright

initialise

Previous: Not converted

2024-08-12

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.07
vs -0.28

Q1.23

arrow
arrow

N/A

-0.06
vs -0.22

Q2.23

arrow
arrow

N/A

-0.02
vs -0.17

Q3.23

arrow
arrow

N/A

-0.03
vs -0.14

Q4.23

arrow
arrow

N/A

-0.04
vs -0.07

Q1.24

arrow
arrow

N/A

-0.05
vs -0.06

Q2.24

arrow
arrow

N/A

-0.05
vs -0.02

Q3.24

arrow
arrow

N/A

-0.08
vs -0.03

Q4.24

arrow
arrow

N/A

-0.07
vs -0.04

Q1.25

arrow
arrow

N/A

-0.06
vs -0.05

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+312%

235K  vs 57K

Q3.22

arrow
arrow

-83%

220K  vs 1.3M

Q4.22

arrow
arrow

-100%

705  vs 251K

Q1.23

arrow
arrow

-100%

NA  vs 250K

Q2.23

arrow
arrow

NA

235K  vs 235K

Q3.23

arrow
arrow

-100%

NA  vs 220K

Q4.23

arrow
arrow

-33433%

-235000.00  vs 705

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

-100%

NA  vs 235K

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-13%

-0.13
vs -0.19

Q1.23

arrow
arrow

-1184%

-11.84
vs -0.13

Q2.23

arrow
arrow

-12%

-0.12
vs -11.84

Q3.23

arrow
arrow

-21%

-0.21
vs -0.12

Q4.23

arrow
arrow

-47%

-0.47
vs -0.21

Q1.24

arrow
arrow

-98%

-0.98
vs -0.47

Q2.24

arrow
arrow

-31%

-0.31
vs -0.98

Q3.24

arrow
arrow

-13%

-0.13
vs -0.31

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

62

62
vs 40

55%

Q1.23

arrow
arrow

99

99
vs 62

60%

Q2.23

arrow
arrow

102

102
vs 99

3%

Q3.23

arrow
arrow

94

94
vs 102

-8%

Q4.23

arrow
arrow

97

97
vs 94

3%

Q1.24

arrow
arrow

106

106
vs 97

9%

Q2.24

arrow
arrow

133

133
vs 106

25%

Q3.24

arrow
arrow

189

189
vs 133

42%

Earnings Growth

Latest News